Allogeneic mesenchymal stem cell infusion therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic mesenchymal stem cell infusion therapy, covering 2022-05-11 to 2026-06-16. Get the full timeline:
Most recent: Clinical Trial Results: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) [Phase 1, Phase 2]